To establish a Medicare patient IVIG access demonstration project.

Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

DME Competitive Bidding, H.R. 5597: To Establish a Medicare Patient IVIG Access Demonstration Project, H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009, Medicare Coverage of Diabetic Testing Supplies

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare demonstration projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value; competitive bidding; proposed revisions to the blood glucose local coverage determination H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medicare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act of 2009; all sections S. 1796 - America's Healthy Future Act of 2009; sections 1001 - 2221 H.R. 3790 - To amend Title XVIII of the Social Security Act to repeal the Medicare Competitive Acquisition program for durable medical equipment and prosthetics, orthotics, and supplies (DMEPOS); all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Rate Commission, Postal Regulatory Commission, SENATE, U.S. Postal Service (USPS)

Medicare reimbursement for IVIG, including provisions in HR 5597, re: a demonstration project for the furnishing of IVIG in a Medicare patient's home for treatment of primary immune deficiency diseases.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. H.R. 2002 / S. 701, Medicare Patient IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage & payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 5712, Physician Payment and Therapy Relief Act and H.R. 4994, Medicare and Medicaid Extenders Act, as they relate to Medicare coverage of IVIG services.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. S. 701 / H.R. 2002, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage and payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 5712, Physician Payment and Therapy Relief Act and H.R. 4994, Medicare and Medicaid Extenders Act, as they relate to Medicare coverage of IVIG services. S. 525, S. 1232 / H.R. 1298, the Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. Drug safety issues, including H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree and H.R. 6543, The Drug Safety Enhancement Act.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 701: Medicare Patient IVIG Access Act of 2009 HR 1765: Medicare IVIG Home Infusion Legislation HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration Project Pharmaceutical Industry Annual Fee; Orphan Drug Exclusion Pending acquisition of Talecris by GRIFOLS. Educational meetings with Congressional offices. HR 5141 & S 3578: "Small Business Paperwork Mandate Elimination Act"

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1765: To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intraveneous immune globulin (IVIG) in a patient's home for the treatment of primary immunde deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. HR 5597: To establish a Medicare patient IVIG access demonstration project HR 4994-Medicare and Medicaid Extenders Act of 2010: To establish a Medicare patient IVIG access demonstration project S 701-Medicare Patient IVIG Access Act of 2009 HR 1586-Education, Jobs and Medicaid funding bill as it relates to Medicaid AMP

Client expense: $581,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE, State, Dept of (DOS)

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; Competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program;

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

Drug Utilization Review Program Competitive bidding HR 5597: Medicare Patient IVIG Access Demonstration Project

Client expense: Not reported · Firm income: $30,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

S.701-Medicare Patient IVIG Access Act of 2009 H.R.1765-To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program H.R.5597-To establish a Medicare patient IVIG access demonstration project

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

DME Competitive Bidding H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; Competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program;

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

healthcare reform; healthcare regulations; Medicare Part D; proposed antitrust exemptions for certain pharmacies; IVIG payments; Medicare Demonstration Projects for durable medical equipment; importation of prescription drugs; home infusion; disclosure of PBM information; changes to drug benefits offered under the FEHBP and increasing healthcare value H.R. 574 and S. 254 - Medicare Home Infusion Therapy Coverage Act of 2009; all sections H.R. 1204 - Community Pharmacy Fairness Act of 2009; all sections H.R. 1765 - To Amend Title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program; all sections H.R. 5597 - To Establish a Medciare Patient IVIG Access Demonstration Project; all sections H.R. 4199 - Patient Health and Real Medication Access Cost Savings Act of 2009; all sections H.R. 3962 - Affordable Healthcare for All America Act; all setions S. 1793 - America's Health Future Act of 2009; all sections H.R. 4752 - Medicare Prescription Drug Price Negotiations Act of 2010; all sections Public Law 111-152 - Healthcare and Education Reconciliation Act of 2010 (formerly H.R. 4872); all sections

Client expense: $960,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Personnel Management (OPM), Postal Regulatory Commission, SENATE

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

Client expense: $340,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

DME Competitive Bidding H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1765: To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. H.R. 5597: To establish a Medicare patient IVIG access demonstration project S.701: Medicare Patient IVIG Access Act of 2009 H.R. 1586: Education, Jobs and Medicaid funding bill as it relates to Medicaid AMP

Client expense: $930,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS)

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. S. 701 / H.R. 2002, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage and payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 4213, The Tax Extenders Act as it relates to access to IVIG for Medicare beneficiaries. S. 525, S. 1232 / H.R. 1298, the Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. Drug safety issues, including H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. H.R. 2002 / S. 701, Medicare Patient IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage & payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 4213, The Tax Extenders Act, as it relates to access to IVIG for Medicare beneficiaries.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare reimbursement for IVIG, including provisions in HR 5597, re: a demonstration project for the furnishing of IVIG in a Medicare patient's home for treatment of primary immune deficiency diseases.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug Utilization Review Program Competitive bidding HR 5597: Medicare Patient IVIG Access Demonstration Project

Client expense: Not reported · Firm income: $30,000

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 701: Medicare Patient IVIG Access Act of 2009 HR 1765: Medicare IVIG Home Infusion Legislation HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration Project HR 4213: The American Jobs and Closing Tax Loopholes Act (340B Program inpatient expansion) Pharmaceutical Industry Annual Fee; Orphan Drug Exclusion

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.

Client expense: Not reported · Firm income: $70,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Performance Based Pharmacy Reimbursement/Medication Therapy Management proposal; Postal Service - discussions around 5-day mail delivery; competitive bidding; HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 4489, FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act; S. 369, Preserve Access to Affordable Generics Act; S. 1630, Affordable Access to Prescription Medications Act prescription drug copays and formularies; HR 5597, To establish a Medicare patient IVIG access demonstration project; HR 3790, Repeal of DMEPOS competitive bidding program; HR 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 / PL 111-192

Client expense: Not reported · Firm income: $80,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3790: Medicare Competitive Bidding for DMEPOS S. 254/H.R. 574: Medicare Home Infusion Therapy Coverage Act of 2009 H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 3590: Patient Protection and Affordable Care Act (PPACA)

Client expense: $170,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. S. 701 / H.R. 2002, Medicare IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage and payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 4213, The Tax Extenders Act as it relates to access to IVIG for Medicare beneficiaries. S. 525, S. 1232 / H.R. 1298, the Pharmaceutical Market Access & Drug Safety Act, as it relates to the importation of biologicals and pedigree. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare and Medicaid reimbursement issues for certain drugs and biologicals; all issues related to Medicare coverage of pre-ESRD education. H.R. 2002 / S. 701, Medicare Patient IVIG Access Act as it relates to Medicare coverage of IVIG services. H.R. 1765, as it relates to Medicare coverage & payment for IVIG administered in the home. H.R. 5597, To establish a Medicare patient IVIG access demonstration project. H.R. 4213, The Tax Extenders Act, as it relates to access to IVIG for Medicare beneficiaries.

Client expense: Not reported · Firm income: $57,500

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Medicare reimbursement for IVIG, including provisions in HR 5597, re: a demonstration project for the furnishing of IVIG in a Medicare patient's home for treatment of primary immune deficiency diseases.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending. H.R. 4872: The Health Care and Education Reconciliation Act. S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP. H.R.1765: To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. H.R. 5597: To establish a Medicare patient IVIG access demonstration project H.R. 4899: Small Business and Infrastructure Jobs Tax Act of 2010, specific focus on Average Manufacturer Price (AMP) calculation for Medicaid drugs. H.R. 4213: American Jobs and Closing Tax Loopholes Act of 2010, specific focus on Average Manufacturer Price (AMP) calculation for Medicaid drugs, changes to 340B drug discount program and international tax provisions and research and development tax credits. H.R. 4846: Bleeding Disorder Screening, Awareness, and Further Education (SAFE) Act of 2010 S.701: A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG). S. 1796/H.R. 3200: America's Healthy Future Act, as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices.

Client expense: $950,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Natl Economic Council (NEC), SENATE, State, Dept of (DOS)

S 701: Medicare Patient IVIG Access Act of 2009 HR 1765: Medicare IVIG Home Infusion Legislation HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration Project HR 4213: The American Jobs and Closing Tax Loopholes Act (340B Program inpatient expansion) Pharmaceutical Industry Annual Fee; Orphan Drug Exclusion

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE